UniQure Reeling As FDA Reverses Stance On Accelerated Approval For AMT-130

 
• By Joseph Haas
  
Uniqure interior
UniQure may need to revise its BLA filing plans for AMT-130 • Source: UniQure
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies